Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Keros upsizes IPO, raising $96M for midphase trials

fiercebiotechApril 13, 2020

Tag: Keros Therapeutics , hematological , musculoskeletal indications , KER-050

PharmaSources Customer Service